Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr David Llobet-Navas.

Newcastle AuthorsTitleYearFull text
Dr David Llobet-Navas
Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer2017
Dr David Llobet-Navas
Endometrial Carcinoma: Specific Targeted Pathways2017
Dr David Llobet-Navas
Immunohistochemical analysis of T-type calcium channels in acquired melanocytic nevi and melanoma2017
Dr Ruth Rodriguez Barrueco
Dr David Llobet-Navas
miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapy2017
Dr David Llobet-Navas
Overexpression of JARID1B promotes differentiation via SHIP1/AKT signaling in human hypopharyngeal squamous cell carcinoma2016
Dr David Llobet-Navas
Cupid: simultaneous reconstruction of microRNA-target and ceRNA networks2015
Dr David Llobet-Navas
HDAC6 activity is a non-oncogene addiction hub for in inflammatory breast cancers2015
Dr Ruth Rodriguez Barrueco
Dr David Llobet-Navas
Inhibition of the autocrine IL-6-JAK2-STAT3-calprotectin axis as targeted therapy for HR-/HER2+ breast cancers2015
Dr David Llobet-Navas
A NOTCH1-driven MYC enhancer promotes T-cell development, transformation and acute lymphoblastic leukemia2014
Dr David Llobet-Navas
Integration of Genomic Data Enables Selective Discovery of Breast Cancer Drivers2014
Dr David Llobet-Navas
The miR-424(322)/503 cluster orchestrates remodeling of the epithelium in the involuting mammary gland2014
Dr David Llobet-Navas
Dr Ruth Rodriguez Barrueco
The microRNA-424/503 cluster reduces CDC25A expression during cell cycle arrest imposed by β in mammary epithelial cells2014